Assay Report Card

Basic Information

ID: ALA3887058

Type: Binding

Description: Cell Free Inhibition Assay: The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by determining the concentration of inhibitor at which 50% of the nitrocefin hydrolysis is inhibited by the particular enzyme. Assays are performed with beta -lactamases expressed in the pET system (Novagen, San Diego, Calif.) without signal peptides. They contain an N-terminal hexa-Histidine tag that is used for purification on Ni-NTA (Qiagen, Hilden, Germany). The compounds are prepared as 50 mM stocks in DMSO and diluted into buffer P1 (50 mM phosphate, pH 7) to a final concentration of 10% DMSO. All further dilutions are done in P2 (P1 with 10% DMSO). Enzyme and compound dilutions are pre-incubated for 10 min at 37 C. and the reaction is started with the addition of pre-warmed (37 C.) nitrocefin at a final concentration of 50 mM. The change in absorption at 490 nm is followed at 37 C. for 10 min with 30 s intervals.

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
233.24-0.79-0.79
300.30-1.52-1.52
199.16-1.10-1.10
403.433.243.24
327.341.671.67
427.452.592.59
253.21-0.38-0.38
384.351.571.57
393.130.120.12
343.341.281.28
327.341.671.67
253.21-0.38-0.38
359.381.571.57
357.361.081.08
455.252.172.17
443.452.482.48
345.351.481.48
343.341.561.56
596.644.814.81
343.341.601.60
357.361.081.08
267.240.030.03
255.230.170.17
419.433.133.13
269.250.260.26
251.240.150.15
251.240.150.15
343.341.561.56
469.231.691.69
419.433.133.13
329.351.511.51
405.453.043.04
427.452.592.59